Published in J Antimicrob Chemother on August 02, 2011
Sexual risk behavior among youth with perinatal HIV infection in the United States: predictors and implications for intervention development. Clin Infect Dis (2012) 1.26
A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe). BMC Infect Dis (2013) 0.94
High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain. PLoS One (2012) 0.93
High viremia and low level of transmitted drug resistance in anti-retroviral therapy-naïve perinatally-infected children and adolescents with HIV-1 subtype C infection. BMC Infect Dis (2012) 0.93
Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in Spain. PLoS One (2013) 0.83
Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz. Pediatric Health Med Ther (2014) 0.79
Relationship between viral load and behavioral measures of adherence to antiretroviral therapy in children living with human immunodeficiency virus in Latin America. Braz J Infect Dis (2015) 0.78
Clinical Determinants of HIV-1B Between-Host Evolution and their Association with Drug Resistance in Pediatric Patients. PLoS One (2016) 0.75
Impact of lopinavir-ritonavir exposure in HIV-1 infected children and adolescents in Madrid, Spain during 2000-2014. PLoS One (2017) 0.75
Antiretroviral treatment failure, drug resistance, and subtype diversity in the only pediatric HIV clinic in Rhode Island. Clin Infect Dis (2015) 0.75
Hyponatremic dehydration as a presentation of cystic fibrosis. Pediatr Emerg Care (2006) 1.71
Subclinical atherosclerosis and markers of immune activation in HIV-infected children and adolescents: the CaroVIH Study. J Acquir Immune Defic Syndr (2014) 1.56
The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J Infect (2012) 1.24
Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected. PLoS One (2011) 1.24
The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults. AIDS (2013) 1.19
Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain. Curr HIV Res (2008) 1.03
Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain. J Med Virol (2006) 0.99
Assessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection. Clin Diagn Lab Immunol (2005) 0.96
A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe). BMC Infect Dis (2013) 0.94
High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain. PLoS One (2012) 0.93
Phylogenetic and demographic characterization of HIV-1 transmission in Madrid, Spain. Infect Genet Evol (2013) 0.91
Impact of ethnicity and HIV type 1 subtype on response to first-line antiretroviral therapy. AIDS Res Hum Retroviruses (2007) 0.90
Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses. J Clin Microbiol (2011) 0.90
Tuberculin skin test in bacille Calmette-Guérin-vaccinated children: how should we interpret the results? Eur J Pediatr (2012) 0.89
Molecular surveillance of HIV-1 in Madrid, Spain: a phylogeographic analysis. J Virol (2011) 0.89
Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS). Antiviral Res (2010) 0.86
Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration. J Antimicrob Chemother (2012) 0.86
Safety and antiviral response at 12 months of lopinavir/ritonavir therapy in human immunodeficiency virus-1-infected children experienced with three classes of antiretrovirals. Pediatr Infect Dis J (2005) 0.86
Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain. J Med Virol (2004) 0.86
[Dried blood spots for monitoring HIV infection in Public Health Programs in developing countries]. Enferm Infecc Microbiol Clin (2012) 0.85
Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007). AIDS Res Hum Retroviruses (2009) 0.85
The maturation inhibitor bevirimat (PA-457) can be active in patients carrying HIV type-1 non-B subtypes and recombinants. Antivir Ther (2008) 0.84
New findings on transcription regulation across different HIV-1 subtypes. AIDS Rev (2006) 0.84
Reconstructing the timing and dispersion routes of HIV-1 subtype B epidemics in the Caribbean and Central America: a phylogenetic story. PLoS One (2013) 0.83
Drug resistance prevalence in human immunodeficiency virus type 1 infected pediatric populations in Honduras and El Salvador during 1989-2009. Pediatr Infect Dis J (2011) 0.83
Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis. Pediatr Infect Dis J (2012) 0.83
Genetic analysis of regulatory, promoter, and TAR regions of LTR sequences belonging to HIV type 1 Non-B subtypes. AIDS Res Hum Retroviruses (2005) 0.82
Neuroimmunomodulation during exercise: role of catecholamines as 'stress mediator' and/or 'danger signal' for the innate immune response. Neuroimmunomodulation (2007) 0.82
Dried blood as an alternative to plasma or serum for Trypanosoma cruzi IgG detection in screening programs. Clin Vaccine Immunol (2013) 0.82
Clinical presentation and characteristics of pharyngeal adenovirus infections. Pediatr Infect Dis J (2005) 0.81
Effect of nutritional status on Tuberculin skin testing. Indian J Pediatr (2012) 0.80
Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression. Virus Genes (2006) 0.80
Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants. Antiviral Res (2010) 0.80
[Emergence of a single clone of community-associated methicillin-resistant Staphylococcus aureus in southern Madrid children]. Enferm Infecc Microbiol Clin (2006) 0.80
Prevalence of primary resistance mutations to integrase inhibitors in treatment-naïve and -experienced patients infected with B and non-B HIV-1 variants. HIV Clin Trials (2013) 0.79
Staphylococcus aureus abscesses: methicillin-resistance or Panton-Valentine leukocidin presence? Arch Dis Child (2013) 0.78
[Regulation of transcription in different HIV-1 subtypes]. Enferm Infecc Microbiol Clin (2005) 0.78
Impact of highly active antiretroviral therapy on CD4+ T cells and viral load of children with AIDS: a population-based study. AIDS Res Hum Retroviruses (2004) 0.78
Cardiac function in vertically HIV-infected children and adolescents in the era of highly active antiretroviral therapy. Pediatr Infect Dis J (2015) 0.78
Immunological recovery and metabolic disorders in severe immunodeficiency HIV type 1-infected children on highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2008) 0.78
The new face of the pediatric HIV epidemic in Western countries: demographic characteristics, morbidity and mortality of the pediatric HIV-infected population. Pediatr Infect Dis J (2015) 0.77
[New diagnosis of HIV infection in children]. Enferm Infecc Microbiol Clin (2011) 0.77
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia. Clin Infect Dis (2016) 0.77
[Epidemiology of drug-resistant HIV-1 transmission in naïve patients in Spain]. Med Clin (Barc) (2009) 0.77
PEGylated poly(ethylene imine) copolymer-delivered siRNA inhibits HIV replication in vitro. J Control Release (2011) 0.77
Prospective evaluation of a clinical guideline recommending early patients discharge in bleeding peptic ulcer. J Gastroenterol Hepatol (2010) 0.77
[Recommendations of the CEVIHP/SEIP/AEP/PNS on antiretroviral treatment in HIV-infected children and teenagers]. Enferm Infecc Microbiol Clin (2005) 0.77
Vector replication and expression of HIV-1 antigens by the HIV/AIDS vaccine candidate MVA-B is not affected by HIV-1 protease inhibitors. Virus Res (2012) 0.76
Implementation of occult hepatitis screening in the Spanish cohort of HIV-infected pediatric patients. Pediatr Infect Dis J (2013) 0.76
Once-daily antiretroviral therapy in a cohort of HIV-infected children and adolescents. Pediatr Infect Dis J (2014) 0.76
Description and consequences of prescribing off-label antiretrovirals in the Madrid Cohort of HIV-infected children over a quarter of a century (1988-2012). Antivir Ther (2015) 0.76
Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence. Pediatr Infect Dis J (2017) 0.76
Bone disease and HIV infection. Clin Infect Dis (2006) 0.75
Ganciclovir treatment of children with congenital cytomegalovirus infection. Pediatr Infect Dis J (2004) 0.75
Possible role of Artemis c.512C>G polymorphic variant in Omenn syndrome. DNA Repair (Amst) (2010) 0.75
Postexposure infant prophylaxis in high-risk situations of human immunodeficiency virus type 1 transmission. Pediatr Infect Dis J (2012) 0.75
Author response to Tebruegge, et al. Arch Dis Child (2012) 0.75
Initial antiretroviral drugs. Pediatr Infect Dis J (2007) 0.75
Prevalence of Elevated Blood Pressure in HIV-infected Children, Adolescents and Young Adults. Pediatr Infect Dis J (2016) 0.75
Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management. Pediatr Infect Dis J (2017) 0.75
[Early diagnosis of congenital cytomegalovirus infection: lost opportunities]. Enferm Infecc Microbiol Clin (2012) 0.75
[Retroviral long terminal repeats: structure and function]. Med Clin (Barc) (2003) 0.75
Bone and Joint Infections. Pediatr Infect Dis J (2017) 0.75
Clinical Features Before Hematopoietic Stem Cell Transplantation or Enzyme Replacement Therapy of Children With Combined Immunodeficiency. Pediatr Infect Dis J (2016) 0.75
Functionally defective high-density lipoproteins are related to heightened T-cell activation in vertically HIV-infected adolescents. J Acquir Immune Defic Syndr (2014) 0.75
Cardiovascular risk markers are increased in HIV-infected children with lipodystrophy syndrome. J Infect (2011) 0.75
[Septic arthritis with negative cultures, usefulness of molecular techniques]. Enferm Infecc Microbiol Clin (2012) 0.75
Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-Infected Pediatric Population in Madrid: 1993-2015 Analysis. Pediatr Infect Dis J (2017) 0.75
Unsuspected Congenital Tuberculosis. Pediatr Infect Dis J (2016) 0.75
Association between a suppressor combined antiretroviral therapy containing Maraviroc and the hepatitis B virus vaccine response. Antimicrob Agents Chemother (2017) 0.75
New diagnoses of human immunodeficiency virus infection in the Spanish pediatric HIV Cohort (CoRISpe) from 2004 to 2013. Medicine (Baltimore) (2017) 0.75
[Plasma antiretroviral levels in children with human immunodeficiency virus infection. Influence of sex and age]. Enferm Infecc Microbiol Clin (2010) 0.75